Adaptimmune Therapeutics PLC
ADAPY- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001621227
No open-market purchases or sales by Adaptimmune Therapeutics PLC insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Adaptimmune Therapeutics PLC changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Of which not filed for Q2 2025 | Q2 2025 | Change |
|---|---|---|---|---|
| Holders | 67 | 2 | 65 | 0 |
| Shares | 116.1M | 5.66K | 115.6M | −473.5K (−0.4%) |
| Value | $22.9M | $1.11K | $27.7M | +$4.84M (+21.2%) |
2 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held Adaptimmune Therapeutics PLC at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Empirical Finance, LLC | 800,000 | $191.8K | 0.01% |
| Almitas Capital LLC | 109,054 | $26.1K | 0.01% |
| XTX Topco Ltd | 80,022 | $19.2K | 0.00% |
| Wiley Bros.-Aintree Capital, LLC | 20,000 | $4.79K | 0.00% |
| PKS Advisory Services, LLC | 17,000 | $4.08K | 0.00% |
| Kornitzer Capital Management Inc | 10,000 | $2.40K | 0.00% |
| Baader Bank INC | 14,935 | $2.21K | 0.00% |
| V. M. Manning & Co., Inc. | 22,200 | $1.39K | 0.00% |
| Garde Capital, Inc. | 750 | $180 | 0.00% |
| Northwestern Mutual Wealth Management Co | 153 | $37 | 0.00% |
| Koesten, Hirschmann & Crabtree, INC. | 47 | $12 | 0.00% |
Sold out (11)
Institutions that held Adaptimmune Therapeutics PLC at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Two Sigma Investments, LP | 135,947 | $26.8K |
| Millennium Management LLC | 94,283 | $18.6K |
| Graham Capital Management, L.P. | 87,274 | $17.2K |
| Invesco Ltd. | 78,031 | $15.4K |
| CSS LLC | 30,702 | $6.05K |
| HSBC Holdings PLC | 26,064 | $5.21K |
| Goldman Sachs Group Inc | 16,149 | $3.18K |
| Qube Research & Technologies Ltd | 10,113 | $1.99K |
| CIBC Private Wealth Group, LLC | 3,023 | $682 |
| Group One Trading, L.P. | 147 | $29 |
| Farther Finance Advisors, LLC | 20 | $5 |
Not filed for Q2 2025 yet (2)
Institutions that held Adaptimmune Therapeutics PLC at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Lindbrook Capital, LLC | 4,610 | $908 |
| Sandy Spring Bank | 1,050 | $207 |